Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Pennsylvania Business Bulletin.
Press releases published on June 6, 2025
Broadway Technology Inc Announces Entering into a Merger Agreement with Quartzsea Acquisition Corporation
GlobeNewswire
·
June 6, 2025
HAINING, China, June 06, 2025 (GLOBE NEWSWIRE) -- Broadway Technology Inc (“Gaokai”), a leading manufacturer of high-quality PET (polyethylene terephthalate) cups and lids through its operating subsidiary Zhejiang Gaokai New Materials Co., Ltd., announced …
Magnetic North Acquisition Corp. Provides Bi-Weekly Update On Status Of Management Cease Trade Order
GlobeNewswire
·
June 6, 2025
CALGARY, Alberta and TORONTO, June 06, 2025 (GLOBE NEWSWIRE) -- Magnetic North Acquisition Corp. (TSXV: MNC; MNC.PR.A) (“Magnetic North” or the “Company”) is providing this bi-weekly update on the status of the management cease trade order granted on May 9 …
Opendoor Announces Preliminary Proxy Filing Seeking Approval for Discretionary Reverse Stock Split
GlobeNewswire
·
June 6, 2025
SAN FRANCISCO, June 06, 2025 (GLOBE NEWSWIRE) -- Opendoor Technologies Inc. (Nasdaq: OPEN) (the “Company,” “Opendoor,” “we,” “our” or “us”), a leading e-commerce platform for residential real estate transactions, filed a preliminary proxy statement. The …
SRQ Resources Announces Results of AGM
GlobeNewswire
·
June 6, 2025
MONTREAL, June 06, 2025 (GLOBE NEWSWIRE) -- SRQ Resources Inc. (TSX-V: SRQ) (“SRQ” or the “Company”) today announces that all nominees listed in the management proxy circular were elected as directors of the Company at its annual general meeting of …
Rakovina Therapeutics Announces the Closing of Oversubscribed Private Placement of $4.9 Million
GlobeNewswire
·
June 6, 2025
VANCOUVER, British Columbia, June 06, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered …
RESTEM to Present Phase 2/3 IIMPACT Trial Design in Idiopathic Inflammatory Myopathy at EULAR 2025 Congress
GlobeNewswire
·
June 6, 2025
MIAMI, June 06, 2025 (GLOBE NEWSWIRE) -- RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to modulate the immune system, today announced that it will present the rationale and study design …
Online Slots Real Money: SlotoCash Expands Real Money Slots Collection
GlobeNewswire
·
June 6, 2025
Las Vegas, June 06, 2025 (GLOBE NEWSWIRE) -- The SlotoCash upgrades will include immersive themes, more variety, and high-stakes possibilities for gamers in search of fortune and fun. The announcement is in line with SlotoCash’s dedication to becoming the …
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 6, 2025
SAN FRANCISCO, June 06, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and …
PolyPid to Host Conference Call and Webcast to Discuss D-PLEX₁₀₀ SHIELD II Phase 3 Trial Topline Results on Monday, June 9, 2025
GlobeNewswire
·
June 6, 2025
PETACH TIKVA, Israel, June 06, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD), (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will host a conference call and webcast to report …
Globalink Investment Inc. Announces Extension of the Deadline to Complete a Business Combination to July 9, 2025
GlobeNewswire
·
June 6, 2025
New York, NY , June 06, 2025 (GLOBE NEWSWIRE) -- Globalink Investment Inc. (OTC Pink: GLLI, GLLIW, GLLIR, GLLIU) (“Globalink” or the “Company”), a special purpose acquisition company, announced today that on June 5, 2025, it caused to be deposited $0.15 …
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 6, 2025
MALVERN, Pa., June 06, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing …
Enovis to Participate in Upcoming Investor Conferences
GlobeNewswire
·
June 6, 2025
Wilmington, DE, June 06, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences: Goldman Sachs 46th …
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 6, 2025
WOBURN, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced the grant of inducement equity awards to newly …
Keros Therapeutics Announces Participation at Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire
·
June 6, 2025
LEXINGTON, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders …
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
GlobeNewswire
·
June 6, 2025
Company announcement – No. 14 / 2025 Zealand Pharma increases its share capital as a result of the exercise of employee warrants Copenhagen, Denmark, June 6, 2025 – Zealand Pharma A/S (“Zealand Pharma”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a biotechnology …
CODI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Compass Diversified Holdings Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
June 6, 2025
NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …
NPWR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that NET Power Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
June 6, 2025
NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz …
OGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
June 6, 2025
NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …
LPRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Open Lending Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
June 6, 2025
NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 6, 2025
WESTLAKE VILLAGE, Calif., June 06, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an …